When did Intellia Therapeutics report Q4 2024 earnings?

Intellia Therapeutics (NTLA) reported Q4 2024 earnings on February 27, 2025 before market open.

What were Intellia Therapeutics's Q4 2024 revenue and EPS?

Intellia Therapeutics reported revenue of $12.9M and eps of $-1.24 for Q4 2024.

Did Intellia Therapeutics beat estimates in Q4 2024?

Revenue beat the consensus estimate of $10.9M by $2.0M. EPS beat the consensus estimate of $-1.32 by $0.08.

Where can I find Intellia Therapeutics's Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-029007) directly on SEC EDGAR. The filing index links above go to sec.gov.

Intellia Therapeutics NTLA Q4 2024 Annual earnings

Reported February 27, 2025 · Before market open

Revenue$12.9MBeat by $2.0M

EPS-$1.24Beat by $0.08

Revenue estimate$10.9M

EPS estimate-$1.32

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$13.0M

EPS estimate-$0.80

Financials

Q4 2024

Income statement

See full

Revenue$12.9M—

Operating income-$136.4M+2.5%

Net income-$128.9M+2.5%

EPS (diluted)-$1.26+13.7%

Balance sheet

See full

Cash & equivalents$189.2M-16.6%

Total debt$210.2M+82.2%

Total equity$872.0M-17.0%

Total assets$1.2B-8.5%

Cash flow

See full

Operating cash flow-$85.2M+8.4%

CapEx$981.0K-35.5%

Free cash flow-$86.2M+8.9%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$1.19B-56.9%

Enterprise value$1.21B-54.3%

P/S20.5×-51.7×

Profitability

See full

Operating margin-923.1%-222pp

Net margin-896.8%-201pp

FCF margin-612.8%-183pp

Returns & leverage

See full

Return on equity-54%+21.3pp

Debt / equity0.2×+0.1×

Current ratio5.8×-2.9×

Versus estimates

Revenue

Q1 2026$15.0MBeat by $1.2M Q4 2025$23.0MBeat by $11.0M Q3 2025$13.8MBeat by $1.6M Q2 2025$14.2MBeat by $181.9K Q1 2025$16.6MBeat by $4.7M

Q4 2024$12.9MBeat by $2.0M

Diluted EPS

Q1 2026-$0.81Beat by $0.11 Q4 2025-$0.83Beat by $0.16 Q3 2025-$0.92Beat by $0.10 Q2 2025-$0.99Beat by $0.04 Q1 2025-$1.10Beat by $0.16

Q4 2024-$1.24Beat by $0.08

Ask the moment Intellia Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Intellia Therapeutics report Q4 2024 earnings?: Intellia Therapeutics (NTLA) reported Q4 2024 earnings on February 27, 2025 before market open.
What were Intellia Therapeutics's Q4 2024 revenue and EPS?: Intellia Therapeutics reported revenue of $12.9M and eps of $-1.24 for Q4 2024.
Did Intellia Therapeutics beat estimates in Q4 2024?: Revenue beat the consensus estimate of $10.9M by $2.0M. EPS beat the consensus estimate of $-1.32 by $0.08.
Where can I find Intellia Therapeutics's Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-029007) directly on SEC EDGAR. The filing index links above go to sec.gov.